An exploratory, randomized, placebo-controlled, double-blind trial of Hypericum perforatum 200CH in preventing and treating fingertip puncture site pain and tenderness
- 17 December 2025
- journal article
- Published by Elsevier in Advances in Integrative Medicine
- Vol. 13 (1)
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Ledum palustre 200cH in preventing injection site pain and tenderness following COVID-19 vaccination: Interim results of a double-blind, randomized, placebo-controlled trialAdvances in Integrative Medicine, 2025
- Effect of Hypericum perforatum oil on prevention ecchymosis and pain associated with subcutaneous heparin injection: A self-controlled single-blind studyAdvances in Integrative Medicine, 2025
- CONSORT 2025 statement: updated guideline for reporting randomized trialsNature Medicine, 2025
- The potential role of Hypericum perforatum in wound healing: A literature review on the phytochemicals, pharmacological approaches, and mechanistic perspectivesPhytotherapy Research, 2024
- Efficacy of virtual reality for pain relief in medical procedures: a systematic review and meta-analysisBMC Medicine, 2024
- Efficacy of Buzzy Device Versus EMLA Cream for Reducing Pain During Needle-Related Procedures in ChildrenPediatric Emergency Care, 2023
- Diagnosis and treatment of nerve injury following venipuncture - A report of two cases -Anesthesia and Pain Medicine, 2021
- The effectiveness of the BuzzyⓇ device to reduce or prevent pain in children undergoing needle-related procedures: The results from a prospective, open-label, randomised, non-inferiority studyInternational Journal of Nursing Studies, 2021
- Melatonin for anaesthetic indications in paediatric patients: a systematic reviewAnaesthesia, 2020
- Reporting data on homeopathic treatments (RedHot): a supplement to CONSORTHomeopathy, 2007